Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
2023 Global Alzheimer'S Disease Drug Market Industry (2029 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include ... Read More
-
Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... Diabetes is a chronic condition brought on by insufficient levels of either insulin synthesis or insulin use. It poses a significant public health challenge and is among the priority communicable diseases targeted by world leaders. ... Read More
-
Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast – 2032
... desire to use opioids, increased opioid tolerance, and withdrawal syndrome when discontinued. In 2022, the highest number of diagnosed prevalent cases of Opioid Use Disorder (OUD) was observed in the United States among the 7MM. ... Read More
-
Global Epilepsy Drugs Market Size study & Forecast, by Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), by Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others) and Regional Analysis, 2023-2030
... is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030. Epilepsy is a neurological disorder characterized by ... Read More
-
Pitolisant Emerging Drug Insight and Market Forecast − 2032
... of the pitolisant for myotonic dystrophy in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Vietnam Pharmaceutical Market Outlook to 2027
... offers opportunities for both domestic and international pharmaceutical companies, with a focus on generic drugs and an increasing emphasis on research and development. With a population of over 98 Mn and a growing affluent class, ... Read More
-
2023 Global Anti-Acne Serum Industry (2029 Outlook)
... reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of ... Read More
-
RPL554 Emerging Drug Insight and Market Forecast − 2032
... of the RPL554 for cystic fibrosis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
KALYDECO Drug Insight and Market Forecast − 2032
... KALYDECO for cystic fibrosis in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 –2032 is provided in this report along with a ... Read More
-
CAPLYTA Drug Insight and Market Forecast − 2032
... for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report along with a ... Read More
-
Avexitide Emerging Drug Insight and Market Forecast − 2032
... picture of the avexitide for CHI in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
OXLUMO Drug Insight and Market Forecast − 2032
... the OXLUMO for primary hyperoxaluria in the 6MM, i.e., United States, EU4 (Germany, France, Italy, Spain), the United Kingdom for the study period 2019 –2032 is provided in this report along with a detailed description ... Read More
-
RZ358 Emerging Drug Insight and Market Forecast − 2032
... picture of the RZ358 for CHI in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Epilepsy
... can occur in people, and the severity and symptoms of epilepsy may vary from person to person. Some people may experience infrequent seizures that are well controlled by medication while others may experience severe and ... Read More
-
Opioid Use Disorder (OUD) - Epidemiology Forecast–2032
... opioid tolerance, and withdrawal syndrome when discontinued. In 2022, the highest number of diagnosed prevalent cases of Opioid Use Disorder (OUD) was observed in the United States among the 7MM. As per severity-specific cases, it ... Read More
-
ADRCs Emerging Drug Insight and Market Forecast − 2032
... markets. A detailed picture of the ADRCs for chronic wounds in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 ... Read More
-
VOQUEZNA TRIPLE and DUAL PAKs Drug Insight and Market Forecast − 2032
... Helicobacter pylori (H. pylori) infection in the United States. A detailed picture of the VOQUEZNA TRIPLE and DUAL PAKs for H. pylori in the United States for the study period 2019 –2032 is provided in ... Read More
-
Mexiletine Drug Insight and Market Forecast − 2032
... mexiletine for myotonic dystrophy in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report along ... Read More
-
2023 Global Forecast for Parkinson'S Disease (Pd) Drugs Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Middle East & North Africa Veterinary Pharmaceuticals Market By Animal {Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine), Poultry (Breeders, Broilers), Pets (Canine, Feline)}, By Product {Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others), Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others), Anticoccidials (Oral Solutions, Feed Premixes, Others), Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements}, Country, Competition, Forecast & Opportunities, 2018-2028F
... Others), Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others), Anticoccidials (Oral Solutions, Feed Premixes, Others), Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements}, Country, Competition, Forecast & Opportunities, 2018-2028F Middle East & North Africa Veterinary Pharmaceuticals Market will grow ... Read More
-
REXULTI Drug Insight and Market Forecast − 2032
... for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report along with a ... Read More
-
VX-121 Emerging Drug Insight and Market Forecast − 2032
... of the VX-121 for cystic fibrosis in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 –2032 is provided in this report along ... Read More
-
AMO-02 Emerging Drug Insight and Market Forecast − 2032
... of the AMO-02 for myotonic dystrophy in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
LATUDA Drug Insight and Market Forecast − 2032
... for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report along with a ... Read More
-
LYBALVI Drug Insight and Market Forecast − 2032
... for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report along with a ... Read More
Research Assistance
